Expression and clinical implication of HIF-1α and VEGF-C in non-small cell lung cancer

Abstract

To study the expression and implication of HIF-1α and VEGF-C in non-small cell lung cancer (NSCLC) and its relationship with clinical pathological features of NSCLC, immunohistochemical SP was used to detect the expression of HIF-1α and VEGF-C proteins in 48 NSCLC tissues and the same para-cancerous tissues. The positive rates of HIF-1α and VEGF-C were 70.8% (34/48) and 68.8% (33/48) respectively. The expression of HIF-1α protein was detected in a significantly greater proportion in NSCLC carcinoma tissues than that in para-cancerous tissues (12.5% and 16.7%, P<0.05). The positive rates of HIF-1α and VEGF-C were correlated with lymph node metastasis and TNM stage. No relationship was found between the two factors and age, sex, pathological subtypes and histological grades. The positive rates between HIF-1α and VEGF-C were correlated (P<0.05). HIF-1α and VEGF-C were over-expressed in NSCLC. They may be involved in the carcinogenesis of NSCLC, and play an important role in invasion and metastasis of NSCLC. HIF-1α and VEGF-C work synergically in the process of NSCLC.

Keywords

lung neoplasm / hypoxia-inducible factor-1α / vascular endothelial growth facor-C

References

[1] CaoY.. Emerging mechanisms of tumor lymphangiogenesis and lymphatic metastasis. Nat Rev Cancer, 2005, 5(9): 1-9

[2] SemenzaG. L.. HIF-1 and human disease: one highly involved factor. Genes Dev, 2000, 14(16): 1983-1991

[3] TaoJ., LiT., LiK., et al.. Effect of HIF-1alpha on VEGF-C induced lymphangiogenesis and lymph nodes metastases of pancreatic cancer. J Huazhong Univ Sci Technol [Med Sci], 2006, 26(5): 562-564

[4] SchoppmannS. F., FenzlA., SchindlM., et al.. Hypoxia inducible factor-1alpha correlates with VEGF-C expression and lymphangiogenesis in breast cancer. Breast Cancer Res Treat, 2006, 99(2): 135-141

[5] HockelM., VaupelP.. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst, 2001, 93(4): 266-276

[6] WangG. L., SemenzaG. L.. Purification and characterization of hypoxia-inducible factor 1. J Biol Chem, 1995, 270(3): 1230-1237

[7] BreierG., LichtA. H., NicolausA., et al.. HIF in vascular development and tumour angiogenesis. Novartis Found Symp, 2007, 283(1): 126-133

[8] ZielloJ. E., JovinI. S., HuangY.. Hypoxia-inducible factor (HIF)-1 regulatory pathway and its potential for therapeutic intervention in malignancy and ischemia. Yale J Biol Med, 2007, 80(2): 51-60

[9] KimH. J., ChungH., YooY. G., et al.. Inhibitor of DNA binding 1 activates vascular endothelial growth factor through enhancing the stability and activity of hypoxia-inducible factor-1alpha. Mol Cancer Res, 2007, 5(4): 321-329

[10] DuyndamM. C., van BerkelM. P., DorsmanJ. C., et al.. Cisplatin and doxorubicin repress vascular endothelial growth factor expression and differentially down-regulate hypoxia-inducible factor I activity in human ovarian cancer cells. Biochem Pharmacol, 2007, 74(2): 191-201

[11] JiangH., FengY.. Hypoxia-inducible factor 1alpha (HIF-1alpha) correlated with tumor growth and apoptosis in ovarian cancer. Int J Gynecol Cancer, 2006, 16(1): 405-412

[12] ShinJ. E., JungS. A., KimS. E., et al.. Expression of MMP-2, HIF-1alpha and VEGF in colon adenoma and colon cancer. Korean J Gastroenterol, 2007, 50(1): 9-18

[13] HuangS. P., WuM. S., ShunC. T., et al.. Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma. J Biomed Sci, 2005, 12(1): 229-241

[14] HanzeJ., EulB. G., SavaiR., et al.. RNA interference for HIF-1alpha inhibits its downstream signalling and affects cellular proliferation. Biochem Biophys Res Commun, 2003, 312(3): 571-577

[15] HirakawaS., BrownL. F., KodamaS., et al.. VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood, 2007, 109(3): 1010-1017

[16] IshiiH., YazawaT., SatoH., et al.. Enhancement of pleural dissemination and lymph node metastases of intrathoracic lung cancer cells by vascular endothelial growth factors (VEGFs). Lung Cancer, 2004, 45(3): 325-337

[17] SemenzaG. L.. Involvement of hypoxia-inducible factor 1 in human cancer. Intern Med, 2002, 41(2): 79-83

[18] NilssonI., ShibuyaM., WennstromS.. Differential activation of vascular genes by hypoxia in primary endothelial cells. Exp Cell Res, 2004, 299(2): 476-485

[19] OkadaK., OsakiM., ArakiK., et al.. Expression of hypoxia-inducible factor (HIF-1alpha), VEGF-C and VEGF-D in non-invasive and invasive breast ductal carcinomas. Anticancer Res, 2005, 25(4): 3003-3009

[20] FujiiT., OtsukiT., MoriyaT. e. a1.. Effect of hypoxia on human seminoma cells. Int J Oncol, 2002, 20(5): 955-962